NPR News, Classical and Music of the Delta
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Claiborne Parish Constable Indicted For Selling And Misbranding Illegal Supplements

A federal grand jury has returned an indictment charging William Earl Maddox, 72, of Haynesville, Louisiana, with selling and misbranding illegal supplements online and in stores. Maddox has been charged with two counts of mail fraud, three counts of misbranding of a drug with intent to defraud or deceive, and seven counts of wire fraud.

According to the indictment, from around January 1, 2015 and continuing until about December 31, 2018, Maddox, the elected Constable in Claiborne Parish, Louisiana, sold supplements in capsules in stores and on eBay and websites that he operated, advertising them to be all-natural herbal supplements to treat impotence.

The indictment alleges that Maddox obtained green capsules in unlabeled blister packs in the mail from foreign countries, including China, which contained sildenafil, the active ingredient in the prescription drug Viagra; tadalafil, the active ingredient in the prescription drug Cialis; and testosterone propinionate, an anabolic steroid and a Schedule III controlled dangerous substance.

It is alleged that Maddox had the capsules repackaged and advertised them to contain all natural ingredients but the labeling did not reveal that the capsules contained sildenafil, tadalifil, or testosterone propinionate. The indictment further alleges that when customers purchased these products, payment was made to the PayPal business account for Middle Marketing, LLC, which was Maddox’s company. Maddox would then ship the capsules to customers via the United States Postal Service and transfer the funds generated from the sale of the products from the PayPal account to his Middle Marketing bank account.

If convicted, the defendant faces up to 20 years in prison, a $250,000 fine, or both, on the mail and wire fraud counts and up to 3 years in prison, a $250,000 fine, or both, on the misbranding of a drug with intent to defraud or deceive counts in the indictment.

The U.S. Food and Drug Administration conducted the investigation. Assistant U.S. Attorneys Jessica D. Cassidy and Earl M. Campbell are prosecuting the case.

An indictment is merely an accusation and a defendant is presumed innocent unless and until proven guilty beyond a reasonable doubt.